Joseph Kenneth Keller - Net Worth and Insider Trading

Joseph Kenneth Keller Net Worth

The estimated net worth of Joseph Kenneth Keller is at least $142,140 dollars as of 2024-04-24. Joseph Kenneth Keller is the EVP & COO of Spectrum Pharmaceuticals Inc and owns about 138,000 shares of Spectrum Pharmaceuticals Inc (SPPI) stock worth over $142,140. Details can be seen in Joseph Kenneth Keller's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Joseph Kenneth Keller has not made any transactions after 2012-11-12 and currently still holds the listed stock(s).

Transaction Summary of Joseph Kenneth Keller

To

Joseph Kenneth Keller Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joseph Kenneth Keller owns 1 companies in total, including Spectrum Pharmaceuticals Inc (SPPI) .

Click here to see the complete history of Joseph Kenneth Keller’s form 4 insider trades.

Insider Ownership Summary of Joseph Kenneth Keller

Ticker Comapny Transaction Date Type of Owner
SPPI Spectrum Pharmaceuticals Inc 2012-11-12 EVP & Chief Operating Officer

Joseph Kenneth Keller Latest Holdings Summary

Joseph Kenneth Keller currently owns a total of 1 stock. Joseph Kenneth Keller owns 138,000 shares of Spectrum Pharmaceuticals Inc (SPPI) as of November 12, 2012, with a value of $142,140.

Latest Holdings of Joseph Kenneth Keller

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SPPI Spectrum Pharmaceuticals Inc 2012-11-12 138,000 1.03 142,140

Holding Weightings of Joseph Kenneth Keller


Joseph Kenneth Keller Form 4 Trading Tracker

According to the SEC Form 4 filings, Joseph Kenneth Keller has made a total of 0 transactions in Spectrum Pharmaceuticals Inc (SPPI) over the past 5 years. The most-recent trade in Spectrum Pharmaceuticals Inc is the acquisition of 10,000 shares on November 12, 2012, which cost Joseph Kenneth Keller around $109,500.

Insider Trading History of Joseph Kenneth Keller

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Joseph Kenneth Keller Trading Performance

GuruFocus tracks the stock performance after each of Joseph Kenneth Keller's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joseph Kenneth Keller is 13.3%. GuruFocus also compares Joseph Kenneth Keller's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joseph Kenneth Keller within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Joseph Kenneth Keller's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Joseph Kenneth Keller

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 3.79 13.3 -29.82 -13.11 -17.06 -22.35
Relative Return to S&P 500(%) 0.28 3.2 -48.2 -41.2 -38.59 -36.38

Joseph Kenneth Keller Ownership Network

Ownership Network List of Joseph Kenneth Keller

No Data

Ownership Network Relation of Joseph Kenneth Keller


Joseph Kenneth Keller Owned Company Details

What does Spectrum Pharmaceuticals Inc do?

Who are the key executives at Spectrum Pharmaceuticals Inc?

Joseph Kenneth Keller is the EVP & Chief Operating Officer of Spectrum Pharmaceuticals Inc. Other key executives at Spectrum Pharmaceuticals Inc include See Remarks Nora Brennan , Chief Legal Officer Keith M Mcgahan , and director & CEO & President Thomas J Riga .

Spectrum Pharmaceuticals Inc (SPPI) Insider Trades Summary

Over the past 18 months, Joseph Kenneth Keller made no insider transaction in Spectrum Pharmaceuticals Inc (SPPI). Other recent insider transactions involving Spectrum Pharmaceuticals Inc (SPPI) include a net sale of 200,742 shares made by Thomas J Riga , a net sale of 110,082 shares made by Keith M Mcgahan , and a net purchase of 50,000 shares made by Jeff L Vacirca .

In summary, during the past 3 months, insiders sold 0 shares of Spectrum Pharmaceuticals Inc (SPPI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 343,211 shares of Spectrum Pharmaceuticals Inc (SPPI) were sold and 50,000 shares were bought by its insiders, resulting in a net sale of 293,211 shares.

Spectrum Pharmaceuticals Inc (SPPI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Spectrum Pharmaceuticals Inc Insider Transactions

No Available Data

Joseph Kenneth Keller Mailing Address

Above is the net worth, insider trading, and ownership report for Joseph Kenneth Keller. You might contact Joseph Kenneth Keller via mailing address: 11500 S. Eastern Ave., Suite 240, Henderson Nv 89052.

Discussions on Joseph Kenneth Keller

No discussions yet.